A federal health coverage change meant up to 56M Americans now have access to certain weight loss medications through a new discount pathway.
Eligible beneficiaries enrolled in prescription drug coverage could get some GLP-1 weight loss medications for $50 a mo under the bridge program.
The access test began July 1 and runs through Dec. 31, 2027, giving eligible users more time to use the discount pathway.
Qualification depends on BMI thresholds, with broader access for BMI 35+, and additional health-condition requirements for lower BMI ranges when applying for coverage.
People already receiving these medications through existing prescription drug coverage were not eligible for the bridge, so checking status with a doctor mattered.
US Drug Coverage for Weight Loss
